Is there a Role for Genetics in Cardiac Calcification?

Authors

  • Urban Hellman Umeå University Department of Public Health and Clinical Medicine Umeå, Sweden http://orcid.org/0000-0002-3822-0725
  • Stellan Mörner Umeå University Department of Public Health and Clinical Medicine Umeå, Sweden
  • Michael Henein Umeå University Department of Public Health and Clinical Medicine Umeå, Sweden

DOI:

https://doi.org/10.17987/icfj.v16i0.587

Keywords:

Arterial calcification, gene, coronary artery disease

Abstract

Calcific coronary artery disease (CCAD) may cause abnormal myocardial perfusion and hence generalized ischaemia, despite potential discrepancy in its expression pattern compared to the well-known atherosclerotic disease which raises questions about the exact pathophysiology of coronary calcification and whether there is a genetic aetiology for it.  In a pilot study we studied three candidate genes, ENPP1, ABCC6 and NTE5 which may predispose to coronary arterial or valvular calcification. We studied 65 patients with CCAD and 5 patients with calcific aortic valve disease (CAVD).  Five DNA variants potentially affecting protein function were found in six patients. Our findings support genetic variants might influence the development of CCAD and CAVD, however, segregation in the families must first be performed to ascertain any damaging effect of these variants. The search for direct causative genetic variants in coronary artery and aortic valve calcification must be broadened with other genes.

Author Biography

Michael Henein, Umeå University Department of Public Health and Clinical Medicine Umeå, Sweden

Professor Henein is a senior consultant cardiologist in both Sweden and England who has published over 200 papers and books and lectured worldwide.

He has a special interest in non-invasive cardiology and ground breaking research in cardiac physiology and disease prevention.

References

Bajraktari G, Nicoll R, Ibrahimi P, Jashari F, Schmermund A, Henein MY. Coronary calcium score correlates with estimate of total plaque burden. Int J Cardiol. 2013;167(3):1050-2. 10.1016/j.ijcard.2012.10.082.

Bengrid T, Nicoll R, Zhao Y, Schmermund A, Henein MY. Coronary calcium score is superior to exercise tolerance testing in predicting significant coronary artery stenosis. Int J Cardiol. 2013;168(2):1697-9. 10.1016/j.ijcard.2013.03.071.

Nicoll R, Wiklund U, Zhao Y, Diederichsen A, Mickley H, Ovrehus K, Zamorano J, Gueret P, Schmermund A, Maffei E, Cademartiri F, Budoff M, Henein M. Gender and age effects on risk factor-based prediction of coronary artery calcium in symptomatic patients: A Euro-CCAD study. Atherosclerosis. 2016;252:32-9. 10.1016/j.atherosclerosis.2016.07.906.

Nicoll R, Wiklund U, Zhao Y, Diederichsen A, Mickley H, Ovrehus K, Zamorano P, Gueret P, Schmermund A, Maffei E, Cademartiri F, Budoff M, Henein M. The coronary calcium score is a more accurate predictor of significant coronary stenosis than conventional risk factors in symptomatic patients: Euro-CCAD study. Int J Cardiol. 2016;207:13-9. 10.1016/j.ijcard.2016.01.056.

Doherty TM, Fitzpatrick LA, Shaheen A, Rajavashisth TB, Detrano RC. Genetic determinants of arterial calcification associated with atherosclerosis. Mayo Clin Proc. 2004;79(2):197-210.

Rutsch F, Nitschke Y, Terkeltaub R. Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ Res. 2011;109(5):578-92. 10.1161/CIRCRESAHA.111.247965.

Eltzschig HK, Robson SC. NT5E mutations and arterial calcifications. N Engl J Med. 2011;364(16):1577-8; author reply 9-80. 10.1056/NEJMc1102515#SA1.

Kochan Z, Karbowska J, Gogga P, Kutryb-Zajac B, Slominska EM, Smolenski RT. Polymorphism in exon 6 of the human NT5E gene is associated with aortic valve calcification. Nucleosides Nucleotides Nucleic Acids. 2016;35(10-12):726-31. 10.1080/15257770.2016.1180393.

Hellman U, Morner S, Henein M. Genetic variants in cardiac calcification in Northern Sweden. Medicine (Baltimore). 2019;98(15):e15065. 10.1097/MD.0000000000015065.

Shewan L, Coats A, Henein M. Authors’ Responsibilities and Ethical Publishing. International Cardiovascular Forum Journal. 2018;13:3-4. 10.17987/icfj.v13i0.525.

Downloads

Published

2019-10-07

Issue

Vol. 16 (2019)

Section

Editorial

License

Authors who publish with this journal agree to the following terms:


a. The authors will retain copyright under a Creative Commons Attribution License (CC-BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).